Atea Pharmaceuticals (AVIR) logo

AVIR earnings date, and what happened the last 4 times

Next report

Wed Nov 11

Quality Score today 1

After the close, in 16 days. Expected: the company has not confirmed it.

AVIR closed higher after 2 of its last 4 reports. On average it closed -4.5% the session after a report.

The moment AVIR reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when AVIR reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after AVIR's last 4 reports

AVIR's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 12, 20262026 · After close6estimated+3.0%+0.2%
May 12, 20262026 · After close7estimated-4.5%-16.9%
Mar 5, 20262026 · After close13estimated-9.1%+11.1%
Nov 12, 20252025 · After close9estimated-14.3%-12.6%
  • Aug 12, 2026, after the close: the next session AVIR opened +3.0% and closed +0.2%, and five sessions on it stood +10.5%. Its Quality Score going in was 6 (Average), estimated.
  • May 12, 2026, after the close: the next session AVIR opened -4.5% and closed -16.9%, and five sessions on it stood -24.6%. Its Quality Score going in was 7 (Average), estimated.
  • Mar 5, 2026, after the close: the next session AVIR opened -9.1% and closed +11.1%, and five sessions on it stood +15.1%. Its Quality Score going in was 13 (Above Average), estimated.
  • Nov 12, 2025, after the close: the next session AVIR opened -14.3% and closed -12.6%, and five sessions on it stood -10.0%. Its Quality Score going in was 9 (Average), estimated.

Across these 4 reports AVIR opened higher after 1 of 4 and closed higher after 2 of 4; on average it opened -6.2%, closed -4.5%, and stood -2.2% five sessions on. Its Quality Score is 1 today, against 6 going into its Aug 12, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -16.9% after the May 12, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see AVIR's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about AVIR's earnings

As of Oct 26, 2026: Atea Pharmaceuticals (AVIR): expected to report Wed Nov 11, after the close. AVIR closed higher after 2 of its last 4 reports. Its Quality Score is 1 (Below Average). Scores as of 11:11 PM ET, 15 minutes behind.

When is AVIR's next earnings date?

Expected to report Wed Nov 11, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. AVIR closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does AVIR report before or after the market?

AVIR is expected to report Wed Nov 11, after the close. Its last 4 reports came after the close.

How did AVIR stock react to its last earnings report?

Aug 12, 2026, after the close: the next session AVIR opened +3.0% and closed +0.2%, and five sessions on it stood +10.5%.

Does AVIR stock usually go up after earnings?

AVIR closed higher after 2 of its last 4 reports. On average it closed -4.5% the session after a report, after opening -6.2%. Past behavior, not a forecast.

Atea Pharmaceuticals' page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.